Zimmer Biomet

$150.42 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Zimmer Biomet

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Stock Analysis

last close $150.81
1-mo return 5.6%
3-mo return -5.5%
avg daily vol. 1.01M
52-week high 180.36
52-week low 130.05
market cap. $30.6B
forward pe 18.3
annual div. 0.96
roe 7.6%
ltg forecast 11.2%
dividend yield 0.64%
annual rev. $7.9B
inst own. 92.1%
baraka

Subscribe now for daily local and international financial news

Subscribe